29 Jul Ventolin HFA Inhaler Recall
In case if someone in your family is suffering from asthma, here is important news for you. As per a recent market update, GlaxoSmithKline has recalled around 590,000 Ventolin HFA inhalers from the market. As we know, inhalers are widely used to deliver medications to the patients via lungs and airways; they can be easily obtained from hospitals, retailers, pharmacies, and wholesalers as well.
As per recent reports, these products are observed to be defective; they do not deliver the desired level of medication as per the mentioned dose for the patient. It is important to know that the affected lot numbers among millions of inhalers in the market are 6ZP9848, 6ZP9944, and 6ZP0003. GSK has received so many complains from the market about the building of the product wrapper due to leakage issues. At present, patients need not worry about these defects and the company’s Ventolin inhaler recall because they cannot pose any harm to them.
Juan Carlos Molina, a spokesman recently said that the potential risk about these inhalers is that they may not deliver the prescribed number of actuation to the patients. They are trying to investigate the problem to know the actual cause behind this problem so that desired corrective actions and preventive steps can be executed.
As already stated, it is not a patient level call; in case if you are using an inhaler out of the same defected lot, it is better to contact the customer service team at GSK by calling at 1-888-825-5249. Those who feel that their device is not treating asthma symptoms in the desired manner are advised to contact medical health professionals as soon as possible.
Note that, a property working metered dose inhaler works by releasing a specific dose of medication in the form of an aerosol. Manufacturers design these metered dose albuterol inhalers in such a manner that they ensure the proper delivery of medication via lungs or airways. This mechanism helps to open the airways in the lungs so that few specific medical health conditions like chronic obstructive pulmonary disease and asthma can be elevated.
News updates reveal that GSK issued a class II recall to the lots of Ventolin HFA 200D Inhalers from all retailers, wholesalers, pharmacies, and hospitals within the United States. As per the Food and Drug Administration, the United States, class II Ventolin recall means exposure to such violative products may lead to medically reversible or temporary adverse health problems. Generally, the chances of serious health issues are rare for products covered under Class II recall.
The company recently released a statement according to which if we do the benefit-risk assessment for these HFA 200D Inhalers; it may cause the problem to those patients that are highly dependent on actions to deal with the bronchodilation related conditions. The team also regretted the inconvenience caused to the patients in the market and revealed that they are more concerned about the delivery of high-quality products to the patients.
Those who need to be sure if their product is working fine or not can contact the service team online to avail immediate assistance.